Patent: 5,980,884
✉ Email this page to a colleague
Summary for Patent: 5,980,884
Title: | Methods for retreatment of patients afflicted with Hepatitis C using consensus interferon |
Abstract: | Methods for the retreatment, using a therapeutically effective amount of interferon consensus, of patients with HCV who exhibit serum ALT values above the upper limit of normal after previous treatment with interferon. |
Inventor(s): | Blatt; Larry (Boulder, CO), Klein; Michael (Thousand Oaks, CA) |
Assignee: | Amgen, Inc. (Thousand Oaks, CA) |
Application Number: | 08/595,440 |
Patent Claims: | see list of patent claims |
Details for Patent 5,980,884
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
---|---|---|---|---|---|---|---|
Kadmon Pharmaceuticals Llc | INFERGEN | interferon alfacon-1 | Injection | 103663 | 10/06/1997 | ⤷ Try a Trial | 2039-03-29 |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |
International Patent Family for US Patent 5,980,884
Country | Patent Number | Estimated Expiration |
---|---|---|
South Africa | 97721 | ⤷ Try a Trial |
World Intellectual Property Organization (WIPO) | 9727866 | ⤷ Try a Trial |
Slovakia | 101798 | ⤷ Try a Trial |
Norway | 983410 | ⤷ Try a Trial |
South Korea | 19990082084 | ⤷ Try a Trial |
Japan | 2000504010 | ⤷ Try a Trial |
>Country | >Patent Number | >Estimated Expiration |